|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 5 July 2022, 18:25. The announcement is not marked as price sensitive, and is 21 page(s) in length and 16.3MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 3.082% short sold according to ASIC data. It was ranked the 74th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Change in substantial holding | 5 July 2022, 18:25 |
| VIRALEZE relaunched by LloydsPharmacy in the UK | 30 June 2022, 9:47 |
| SPL signs expanded DEP research agreement with US Biopharma | 27 June 2022, 9:19 |
| Shareholder Newsletter | 3 June 2022, 13:22 |
You must be logged in to post a reply.
Starpharma Holdings 